Genteract’s core technology combines a novel, patented genetic discovery methodology for Identifying gene-environment interactions (GxEs), with a unique genomic+metabolic AI foundation model,  trained and validated on thousands of patients across multiple large scale clinical studies, that together enable functional interpretation of the human genome at a scale that was never previously possible. 

Our vision is a future in which precision medicine is the norm, as a basic standard of care.